Project Description
MS Pharma Ventures Holdings WLL (the “Company”) is a limited liability company incorporated in the Kingdom of Bahrain, active in development, manufacturing and marketing of branded generic pharmaceuticals in Jordan, Algeria, Turkey and other MENA (Middle East and North Africa) countries. Established in 2011 as integrated international pharmaceutical company with three key operating businesses: (i) El Kendi Pharmaceutical Manufacturing Company (Algeria), (ii) United Pharmaceuticals Manufacturing (Jordan), and (iii) MS Pharma Injectibles (Jordan and Turkey). MS Pharma specializes in medication treatment for chronic diseases such as cardiovascular, central nervous system, and respiratory diseases, therapeutic classes which are experiencing high growth rates across MENA region. The Company has invited IFC to support its investment plan of up to US$150 million financing of acquisition opportunities to enter new markets and capacity expansion in its existing facilities (the “Project”).